Sees Q1 adjusted EBITDA loss $20M with sequential improvements throughout 2025.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TWST:
- Options Volatility and Implied Earnings Moves Today, November 18, 2024
- Absci, Twist Bioscience collaborate to design antibody using generative AI
- Xoma enters $15M royalty monetization arrangement with Twist Bioscience
- Twist Bioscience price target raised to $48 from $45 at Leerink
- Twist Bioscience appoints Mike Fero as chief information officer